Study summary · research use only
The Potentials of Methylene Blue as an Anti-Aging Drug
Plain-language summary
Paraphrased from the published abstract below — not a verdict on whether anything works.
This review discusses methylene blue (MB), described as the first fully man-made medicine, and its established clinical uses in surgical staining, malaria, and methemoglobinemia, alongside its anti-oxidative properties. Species not specified. The abstract describes mitochondrial dysfunction as observed in aging across tissues including the brain and skin, contributing to increased oxidative stress and downstream age-related changes. It states MB can bypass Complex I/III activity in mitochondria and reduce oxidative stress to some degree. The review summarizes prior studies on MB's use for age-related conditions, including neurodegeneration, memory loss, skin aging, and the premature aging disease progeria.
Abstract
Methylene blue (MB), as the first fully man-made medicine, has a wide range of clinical applications. Apart from its well-known applications in surgical staining, malaria, and methemoglobinemia, the anti-oxidative properties of MB recently brought new attention to this century-old drug. Mitochondrial dysfunction has been observed in systematic aging that affects many different tissues, including the brain and skin. This leads to increaseding oxidative stress and results in downstream phenotypes under age-related conditions. MB can bypass Complex I/III activity in mitochondria and diminish oxidative stress to some degree. This review summarizes the recent studies on the applications of MB in treating age-related conditions, including neurodegeneration, memory loss, skin aging, and a premature aging disease, progeria.
pepmg summarizes the peer-reviewed literature and links to every source — it sells nothing, ships nothing, and gives no medical, dosing, or human-use guidance. Don't just trust this summary: follow the citation to its source and read it yourself. Research use only.